Zheng Shan, Song Qing-Kun, Zhao Lin, Huang Rong, Sun Li, Li Jing, Fan Jin-Hu, Zhang Bao-Ning, Yang Hong-Jian, Xu Feng, Zhang Bin, Qiao You-Lin
Department of Pathology, Center of Breast Disease, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Asian Pac J Cancer Prev. 2012;13(5):1887-93. doi: 10.7314/apjcp.2012.13.5.1887.
The aim of this study was to detail characteristics of mammary Paget's disease (PD) representing the whole population in China. A total of 4211 female breast cancer inpatients at seven tertiary hospitals from seven representative geographical regions of China were collected randomly during 1999 to 2008. Data for demography, risk factors, diagnostic imaging test, physical examination and pathologic characters were surveyed and biomarker status was tested by immunohistochemistry. The differences of demography and risk factors between PD with breast cancer and other lesions were compared using Chi-square test or t-test, with attention to physical examination and pathological characters. The percentage of PD was 1.6% (68/4211) in all breast cancers. The mean age at diagnosis was 48.1, and 63.2% (43/68) patients were premenopausal. There is no difference in demography and risk factors between PD with breast cancer and other breast cancer (P>0.05). The main pattern of PD in physical exam and pathologic pattern were patients presenting with a palpable mass in breast (65/68, 95.6%) and PD with underlying invasive cancer (82.4%, 56/68) respectively. The rate of multifocal disease was 7.4% (5/68). PD with invasive breast cancer showed larger tumor size, more multifocal disease, lower ER and PR expression and higher HER2 overexpression than those in other invasive breast cancer (P<0.05). These results suggested that PD in China is a concomitant disease of breast cancer, and that PD with underlying invasive cancer has more multiple foci and more aggressive behavior compared with other breast invasive cancer. We address the urgent needs for establishing diagnostic and therapeutic guidelines for mammary PD in China.
本研究旨在详细阐述代表中国全体人群的乳腺佩吉特病(PD)的特征。在1999年至2008年期间,从中国七个具有代表性地理区域的七家三级医院随机收集了4211例女性乳腺癌住院患者。调查了人口统计学、危险因素、诊断性影像学检查、体格检查和病理特征的数据,并通过免疫组织化学检测生物标志物状态。使用卡方检验或t检验比较了伴乳腺癌的PD与其他病变之间的人口统计学和危险因素差异,同时关注体格检查和病理特征。在所有乳腺癌中,PD的比例为1.6%(68/4211)。诊断时的平均年龄为48.1岁,63.2%(43/68)的患者处于绝经前。伴乳腺癌的PD与其他乳腺癌在人口统计学和危险因素方面无差异(P>0.05)。PD在体格检查中的主要表现和病理表现分别为乳房可触及肿块(65/68,95.6%)和伴浸润性癌的PD(82.4%,56/68)。多灶性疾病的发生率为7.4%(5/68)。与其他浸润性乳腺癌相比,伴浸润性乳腺癌的PD肿瘤体积更大、多灶性疾病更多、雌激素受体(ER)和孕激素受体(PR)表达更低、人表皮生长因子受体2(HER2)过表达更高(P<0.05)。这些结果表明,中国的PD是乳腺癌的一种伴发疾病,与其他乳腺浸润性癌相比,伴浸润性癌的PD有更多的病灶且行为更具侵袭性。我们强调了在中国建立乳腺PD诊断和治疗指南的迫切需求。